Why the study?
Do heart-type fatty acid-binding protein and myocardial performance index detect early 5-fluorouracil cardiotoxicity in cancer patients?
Do heart-type fatty acid-binding protein and myocardial performance index detect early 5-fluorouracil cardiotoxicity in cancer patients?
Answers are grounded in this paper and cite their sources.
The Tei index may be a sensitive echocardiographic indicator of occult 5-fluorouracil cardiotoxicity, whereas h-FABP and troponin I do not show significant early changes.
In the present study, we aimed to evaluate temporal changes in heart-type fatty acid-binding protein (h-FABP) and myocardial performance index (Tei index) following administration of 5-fluorouracil (5-FU), a chemotherapeutic agent associated with myocardial ischemia induced by coronary vasospasm. Thirty-two patients with cancer receiving their first 5-FU-based chemotherapy were included in the study. Prior to chemotherapy and 24 hours after the initiation of chemotherapy, all patients underwent a comprehensive echocardiographic examination. Blood samples were taken for h-FABP and troponin I (TnI) measurements at different time points during the first 24 hours of 5-FU administration. Postinfusion echocardiography revealed worsening in Tei index (0.37 ± 0.08 vs 0.43 ± 0.07, P < .001). Clinically overt cardiotoxicity was evident in 4 (12.5%) of our patient population. Heart-type fatty acid binding protein and TnI levels were within normal ranges at all time points. Our results suggest that ischemia coronary vasospasm due to 5-FU cardiotoxicity should be reviewed. Furthermore, Tei index might be a sensitive indicator of occult 5-FU cardiotoxicity.
No takes yet. Share an insight, caveat, or question.
Turan et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: